AMANTA HEALTHCARE LIMITED
AMANTA · General/Diversified · NSE
₹134
Current Market Price
Fair Value (DCF)
₹63
Margin of Safety
-52.8%
Updated 15h ago
YieldIQ Score
31/100
Piotroski F-Score
8/9
Economic Moat
Moderate
Confidence
56%
ROE
—
Debt/Equity
0.88
WACC
11.1%
Market Cap
₹519 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
15.6%
Return on capital employed
EV / EBITDA
9.2×
Enterprise multiple
Debt / EBITDA
3.2×
Leverage vs earnings
Interest Coverage
1.5×
EBIT covers interest
Current Ratio
1.20×
Short-term liquidity
Asset Turnover
0.71×
Revenue per ₹ of assets
Revenue CAGR (3Y)
6.7%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹133.6
Bear case
₹28.64
MoS -366.5%
Base case
₹63.09
MoS -111.8%
Bull case
₹94.55
MoS -41.3%
Ratio Trends
AMANTA · last 4 annual periods
ROE
10.9%
ROCE
20.8%
Operating Margin
—
Debt / Equity
2.00×
PE
—
EV / EBITDA
—
Historical Financials
AMANTA · Annual, last 4 years· amounts in ₹Cr unless noted
| Metric | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|
| Revenue | ₹224 Cr | ₹258 Cr | ₹278 Cr | ₹272 Cr | +6.7% |
| EBITDA | ₹122 Cr | ₹55.4 Cr | ₹57.5 Cr | ₹60.1 Cr | -21.1% |
| EBIT | — | — | — | — | — |
| PAT | ₹53.9 Cr | ₹-2.1 Cr | ₹3.6 Cr | ₹10.5 Cr | -42.0% |
| EPS (diluted) | — | — | — | — | — |
| CFO | ₹63.5 Cr | ₹42.6 Cr | ₹58.1 Cr | ₹46.6 Cr | -9.8% |
| CapEx | ₹-10.0 Cr | ₹-6.3 Cr | ₹-13.4 Cr | ₹-20.8 Cr | — |
| FCF | ₹53.6 Cr | ₹36.3 Cr | ₹44.7 Cr | ₹25.8 Cr | -21.6% |
| Total Assets | ₹379 Cr | ₹374 Cr | ₹352 Cr | ₹382 Cr | +0.2% |
| Total Debt | ₹213 Cr | ₹214 Cr | ₹200 Cr | ₹193 Cr | -3.4% |
| Shareholders' Equity | ₹65.0 Cr | ₹62.9 Cr | ₹66.3 Cr | ₹96.4 Cr | +14.1% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
AMANTA vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
| KILITCH KILITCH | — | — | Pending | 13.3% | — |
| ZIMLAB ZIMLAB | — | — | Pending | 4.8% | — |
| ALBERTDAVD ALBERTDAVD | — | — | Pending | 4.4% | — |
| VALIANTLAB VALIANTLAB | — | — | Pending | -0.9% | — |
| MEDICAMEQ MEDICAMEQ | — | — | Pending | 3.3% | — |
Click a ticker to view its fair-value analysis.
Dividend History
No dividend events recorded for AMANTA in the last 10 years.
AI Analysis Summary
Model-generated description of metrics. Not investment advice. AMANTA HEALTHCARE LIMITED (AMANTA.NS) trades at 133.60 vs a model fair value of 63.09, a gap of -52.8%. Piotroski F-score: 8/9. Moat labe...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of AMANTA →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for AMANTA →
Compare
Head-to-head with peers
Compare AMANTA side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse AMANTANow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.